This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked uk electronic health records databases. Lancet. 2019;394(10203):1041-54. doi: 10.1016/S0140-6736(19)31674-5.StrongmanHGaddSMatthewsAMansfieldKEStanwaySLyonARet alMedium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked uk electronic health records databases20193941020310415410.1016/S0140-6736(19)31674-5Open DOISearch in Google Scholar
Coviello JS. Cardiovascular and cancer risk: the role of cardio-oncology. J Adv Pract Oncol. 2018;9(2):160-76. doi: 10.6004/jadpro.2018.9.2.CovielloJSCardiovascular and cancer risk: the role of cardio-oncology2018921607610.6004/jadpro.2018.9.2Open DOISearch in Google Scholar
Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018;6(3-4):79-100. doi: 10.1142/S2339547818300020.KrzyszczykPAcevedoADavidoffEJTimminsLMMarrero-BerriosIPatelMet alThe growing role of precision and personalized medicine for cancer treatment201863-47910010.1142/S2339547818300020635231230713991Open DOISearch in Google Scholar
Page RL 2nd, O’Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the american heart association. 2016;134(12):e261. Circulation. 2016;134(6):e32-69. doi: 10.1161/CIR.0000000000000426.PageRLO’BryantCLChengDDowTJKyBSteinCMet al201613412e261Circulation. 2016;134(6):e32-6910.1161/CIR.000000000000042627400984Open DOISearch in Google Scholar
Marinko T, Dolenc J, Bilban-Jakopin C. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radiol Oncol. 2014;48(2):105-12. doi: 10.2478/raon-2013-0040.MarinkoTDolencJBilban-JakopinCCardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer20144821051210.2478/raon-2013-0040407802824991199Open DOISearch in Google Scholar
Alvarez JA, Russell RR. Cardio-oncology: the nuclear option. Curr Cardiol Rep. 2017;19(4):31. doi: 10.1007/s11886-017-0844-z.AlvarezJARussellRRCardio-oncology: the nuclear option20171943110.1007/s11886-017-0844-z28315122Open DOISearch in Google Scholar
Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire c30. J Clin Oncol. 2004;22(17):3485-90. doi: 10.1200/JCO.2004.03.025.FrommeEKEilersKMMoriMHsiehYCBeerTMHow accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire c302004221734859010.1200/JCO.2004.03.02515337796Open DOISearch in Google Scholar
Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study. JMIR Mhealth Uhealth. 2020;8(8):e17408. doi: 10.2196/17408.Grašič KuharCGortnar CepedaTKovačTKukarMRužić GorenjecNMobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study202088e1740810.2196/17408743568132427567Open DOISearch in Google Scholar
Drafts BC, Twomley KM, D’Agostino R Jr, Lawrence J, Avis N, Ellis LR, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877-85. doi: 10.1016/j.jcmg.2012.11.017.DraftsBCTwomleyKMD’AgostinoR JrLawrenceJAvisNEllisLRet alLow to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease2013688778510.1016/j.jcmg.2012.11.017374580123643285Open DOISearch in Google Scholar
Giusca S, Korosoglou G, Montenbruck M, Geršak B, Schwarz AK, Esch S, et al. Multiparametric early detection and prediction of cardiotoxicity using myocardial strain, t1 and t2 mapping and biochemical markers: a longitudinal cardiac resonance imaging study during two years of follow-up. Circ Cardiovasc Imaging. 2021;14:e012459. doi: 10.1161/ CIRCIMAGING.121.012459.GiuscaSKorosoglouGMontenbruckMGeršakBSchwarzAKEschSet alMultiparametric early detection and prediction of cardiotoxicity using myocardial strain, t1 and t2 mapping and biochemical markers: a longitudinal cardiac resonance imaging study during two years of follow-up202114e01245910.1161/CIRCIMAGING.121.012459820809234126756Open DOISearch in Google Scholar
Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: esmo clinical practice guidelines. Ann Oncol. 2012;23(Suppl 7):vii155-66. doi: 10.1093/annonc/mds293.CuriglianoGCardinaleDSuterTPlataniotisGde AzambujaESandriMTet alCardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: esmo clinical practice guidelines201223Suppl 7vii1556610.1093/annonc/mds29322997448Open DOISearch in Google Scholar
Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis. 2012;78(3):155-9. doi: 10.4081/monaldi.2012.121.BalestroniGBertolottiGEuroQol-5D (EQ-5D): an instrument for measuring quality of life2012783155910.4081/monaldi.2012.12123614330Open DOISearch in Google Scholar
Eq-5d-5l user guide: basic information on how to use the eq-5d-5l instrument. Accessed March 30th, 2021 at: https://euroqol.org/wp-content/uploads/2019/09/EQ-5D-5L-English-User-Guide_version-3.0-Sept-2019-secured.pdf2021https://euroqol.org/wp-content/uploads/2019/09/EQ-5D-5L-English-User-Guide_version-3.0-Sept-2019-secured.pdfSearch in Google Scholar
Eq-5d (euroqol) • definition | gabler wirtschaftslexikon. Accessed February 27th, 2021 at: https://wirtschaftslexikon.gabler.de/definition/eq-5d-euroqol-517552021https://wirtschaftslexikon.gabler.de/definition/eq-5d-euroqol-51755Search in Google Scholar
Hinz A, Kohlmann T, Stöbel-Richter Y, Zenger M, Brähler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443-7. doi: 10.1007/s11136-013-0498-2.HinzAKohlmannTStöbel-RichterYZengerMBrählerEThe quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population2014232443710.1007/s11136-013-0498-223921597Open DOISearch in Google Scholar
SF-36 Health survey: manual & interpretation guide. Accessed March 30th, 2021 at: https://www.researchgate.net/publication/313050850_SF-36_Health_Survey_Manual_Interpretation_GuideAccessed March 30th2021https://www.researchgate.net/publication/313050850_SF-36_Health_Survey_Manual_Interpretation_GuideSearch in Google Scholar
Sf-36 | springerlink. Accessed March 30th, 2021 at: https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_15972021https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_1597Search in Google Scholar
Ellert U, Bellach BM. Der sf-36 im bundes-gesundheitssurvey - beschreibung einer aktuellen normstichprobe. Gesundheitswesen. 1999;61:S184-90.EllertUBellachBMDer sf-36 im bundes-gesundheitssurvey - beschreibung einer aktuellen normstichprobe199961S18490Search in Google Scholar
Koos R, Altiok E, Doetsch J, Neizel M, Krombach G, Marx N, et al. Layer-specific strain-encoded mri for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease. Int J Cardiol. 2013;166(1):85-9. doi: 10.1016/j. ijcard.2011.10.004.KoosRAltiokEDoetschJNeizelMKrombachGMarxNet alLayer-specific strain-encoded mri for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease2013166185910.1016/j.ijcard.2011.10.00422071039Open DOISearch in Google Scholar
Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and The European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063-93. doi: 10.1093/ehjci/jeu192.PlanaJCGalderisiMBaracAEwerMSKyBScherrer-CrosbieMet alExpert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and The European Association of Cardiovascular Imaging2014151010639310.1093/ehjci/jeu192440236625239940Open DOISearch in Google Scholar
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (esc). Eur Heart J. 2016;37(36):2768-801. doi: 10.1093/ eurheartj/ehw211.ZamoranoJLLancellottiPRodriguezMuñoz DAboyansVAsteggianoRGalderisiMet al2016esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (esc)20163736276880110.1093/eurheartj/ehw21127567406Open DOISearch in Google Scholar
Petek D, Petek-Ster M, Tusek-Bunc K. Health behavior and health-related quality of life in patients with a high risk of cardiovascular disease. Zdr Varst. 2018;57(1):39-46. doi: 10.2478/sjph-2018-0006.PetekDPetek-SterMTusek-BuncKHealth behavior and health-related quality of life in patients with a high risk of cardiovascular disease2018571394610.2478/sjph-2018-0006589436829651314Open DOISearch in Google Scholar
Prevolnik Rupel V, Ogorevc M, IMPACT HTA HRQoL Group. EQ-5D-Y value set for Slovenia. Pharmacoeconomics. 2021;39(4):463-71. doi: 10.1007/s40273-020-00994-4.Prevolnik RupelVOgorevcMIMPACT HTA HRQoL Group. EQ-5D-Y value set for Slovenia20213944637110.1007/s40273-020-00994-4800980033565048Open DOISearch in Google Scholar
Prevolnik Rupel V, Srakar A, Rand K. Valuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets. Zdr Varst. 2020;59(1):8-17. doi: 10.2478/sjph-2020-0002.Prevolnik RupelVSrakarARandKValuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets202059181710.2478/sjph-2020-0002747808432952698Open DOISearch in Google Scholar
Schneider JE, Stojanovic I. Economic evaluation of cardiac magnetic resonance with fast-senc in the diagnosis and management of early heart failure. Health Econ Rev. 2019;9(1):13. doi: 10.1186/s13561-019-0229-7.SchneiderJEStojanovicIEconomic evaluation of cardiac magnetic resonance with fast-senc in the diagnosis and management of early heart failure2019911310.1186/s13561-019-0229-7673430031123926Open DOISearch in Google Scholar
Thavendiranathan P, Wintersperger BJ, Flamm SD, Marwick TH. Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review. Circ Cardiovasc Imaging. 2013;6(6):1080-91. doi: 10.1161/CIRCIMAGING.113.000899.ThavendiranathanPWinterspergerBJFlammSDMarwickTHCardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review20136610809110.1161/CIRCIMAGING.113.00089924254478Open DOISearch in Google Scholar